Nevertheless, levodopa and dopamine agonists are intrinsically different, and the PD‐MED study already showed that levodopa might have a small beneficial effect on mobility relative to dopamine agonists or MAO‐B inhibitors.6 Here, MAOB is linked to Parkinson disease.